Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It occurs when tiny arteries in the lungs, called pulmonary arteries, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through the lungs, and increases pressure within the lungs’ arteries. With increased pressure, the heart has to work harder to pump blood through the lungs, eventually causing the heart muscle to weaken and eventually fail. Pulmonary hypertension is a serious illness that becomes progressively worse and is sometimes fatal.
Feinstein Institute researchers are studying the inflammatory process that occurs during pulmonary hypertension. They are investigating molecules that can change the course of this process and could develop into useful treatments.